What drives multimillion-dollar medical claims? Sun Life report shows secondary health conditions, hospital stays and specialty drugs among key factors
Sun Life U.S. released its annual High-Cost Claims and Injectable Drug Trends report, analyzing over 70,000 high-dollar medical claims from more than 3,300 self-funded employers. The report identifies secondary health conditions, long hospital stays, and specialty drugs as primary drivers of claims exceeding $3 million, with million-dollar+ claims increasing 46% from 2022 to 2026.
Key figures
- Aum
- C$1.58 trillion
- Us employees
- 8,300
- Claims analyzed
- 70,000
- Elevidys avg cost
- $3.6 million
- Us members served
- 48 million
- Employers analyzed
- 3,300
- Blood cancer avg claim
- $5.45 million
- Liver disease avg cost
- $230,000
- Liver disease spend growth
- 43%
- Million dollar claims growth
- 46%
- Highest single leukemia claim
- $8 million
- Glp1 high dollar claims growth
- 24%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.